2017 Myocardial Ischemia pipeline market report of on global industry analysis and opportunity assessment H1 report provides comprehensive information on the therapeutics under development for Myocardial Ischemia (Cardiovascular), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. Get Discount on this Research Report at http://www.reportsnreports.com/contacts/discount.aspx?name=1010746 Lack of blood flow and oxygen to the heart muscle lead to cardiac ischemia, also called myocardial ischemia. The signs and symptoms may include chest pain, typically on the left side of the body (angina pectoris), neck or jaw pain, shoulder or arm pain, clammy skin, shortness of breath and nausea and vomiting. Myocardial ischemia can be caused by conditions such as coronary artery disease (atherosclerosis), blood clot, coronary spasm and severe illnesses. The factors that may increase the risk of developing myocardial ischemia include tobacco, diabetes, high blood pressure, high blood cholesterol or triglyceride levels, lack of physical activity, obesity and family history. Myocardial Ischemia pipeline companies are Angionetics Inc, Bayer AG, Cellmid Ltd, CohBar Inc, Lixte Biotechnology Holdings Inc, NoNO Inc, Omniox Inc, Pathfinder Cell Therapy Inc, Shire Plc, Symic Biomedical Inc, ViroMed Co Ltd. Drug Profiles of Myocardial Ischemia AB-002, alferminogene tadenovec, AntimiR-199a, BAY606583, CMK-103, EP-80317, Humanin, LB-100, OMX-4.80, Pathfinder Cells, Peptagon, PMC-6, SB030, Disorders more.. Purchase this research report Direct from http://www.reportsnreports.com/purchase.aspx?name=1010746 (This report is available at upto 25% Discount till June 02nd 2017.) Scope - The pipeline guide provides a snapshot of the global therapeutic landscape of Myocardial Ischemia (Cardiovascular). - The pipeline guide reviews pipeline therapeutics for Myocardial Ischemia (Cardiovascular) by companies and universities/research institutes based on information derived from company and industry-specific sources. - The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages. - The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities. - The pipeline guide reviews key companies involved in Myocardial Ischemia (Cardiovascular) therapeutics and enlists all their major and minor projects. - The pipeline guide evaluates Myocardial Ischemia (Cardiovascular) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. - The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Myocardial Ischemia (Cardiovascular) Inquire more on this Research Report at http://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=1010746 List of Tables Number of Products under Development for Myocardial Ischemia, H1 2017 Number of Products under Development by Companies, H1 2017 Number of Products under Development by Universities/Institutes, H1 2017 Products under Development by Companies, H1 2017 Products under Development by Universities/Institutes, H1 2017 Number of Products by Stage and Target, H1 2017 Number of Products by Stage and Mechanism of Action, H1 2017 Number of Products by Stage and Route of Administration, H1 2017 Number of Products by Stage and Molecule Type, H1 2017 Myocardial Ischemia - Pipeline by Angionetics Inc, H1 2017 Myocardial Ischemia - Pipeline by Bayer AG, H1 2017 Myocardial Ischemia - Pipeline by Cellmid Ltd, H1 2017 Myocardial Ischemia - Pipeline by CohBar Inc, H1 2017 Myocardial Ischemia - Pipeline by Lixte Biotechnology Holdings Inc, H1 2017 Myocardial Ischemia - Pipeline by NoNO Inc, H1 2017 Myocardial Ischemia - Pipeline by Omniox Inc, H1 2017 Myocardial Ischemia - Pipeline by Pathfinder Cell Therapy Inc, H1 2017 Myocardial Ischemia - Pipeline by Shire Plc, H1 2017 Myocardial Ischemia - Pipeline by Symic Biomedical Inc, H1 2017 Myocardial Ischemia - Pipeline by ViroMed Co Ltd, H1 2017 Myocardial Ischemia - Dormant Projects, H1 2017 Myocardial Ischemia - Discontinued Products, H1 2017 About Us: ReportsnReports.com is single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help in purchase decision by mapping your information needs with our huge collection of reports.